Xuebijing injection and its bioactive components alleviate nephrotic syndrome by inhibiting podocyte inflammatory injury
Article in European Journal of Pharmaceutical Sciences (April 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in European Journal of Pharmaceutical Sciences (April 2024)
Article in Frontiers of Medicine (December 2023)
Article in Advances in Traditional Medicine (September 2023)